The Omnipod Insulin Management System, from the Insulet Corporation, was the world’s first tubeless, wirelessly controlled insulin pump. Worn on the patient’s skin the device automatically and continuously delivers insulin for up to three days. This device, originally stemming from a father whose young boy was diagnosed with diabetes in the 1990’s, transformed his son’s life and the lives of 140,000 diabetics worldwide.
“Patients want more flexible options for delivering medications safely and efficiently” said Bill Rich, vice president of Device Technologies at biotech company Amgen. Combination products like the Omnipod are the solution to the patient’s need for a more personalized health experience. Although there are concerns regarding the regulation of these devices – are they medicine or a device – innovative new methods, such as simulation modeling, are key in accelerating the process of patient trials and driving the devices to market.
Read more about the solutions that are providing patients with life-changing treatment options by navigating to Compass magazine and reading the full article by Rebecca Gibson, “Merging Drugs and Devices” here.
